Income Statement Revium Rx.

Stocks

RVRC

US76151C1009

Market Closed - OTC Markets Other stock markets 07:00:09 30/03/2026 pm IST			5-day change	1st Jan Change
1.670 ^USD	+11.33%		-.--%	+221.15%

22/06	Revium Rx. Announces Resignation of Inna Martin from Director, Chief Operating Officer and President, Effective June 16, 2026	CI
01/06	Revium Rx. Announces CFO Changes, Effective May 27, 2026	CI

32566f93bb0d8.bPFyRze7SP6QGw-CJglUX3vc3DEgRFeqeInIqjIMx7Y.NYUkAkDKPMeib1XpZE45Jk3v6XZODDLuO7n8wEJNo9ICnUQrXIsXi-NZPw

Published financial data: REVIUM RX.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2022	2023	2024	2025
Selling General & Admin Expenses, Total	11.24L	7L	14.1L	18.2L
R&D Expenses	67T	7T	21.58L	16.44L
Other Operating Expenses, Total	11.91L	7L	35.68L	34.64L
Operating Income	-11.91L	-7L	-35.68L	-34.64L
Interest Expense, Total	-22T	-3T	-2T	-
Interest And Investment Income	-	-	65T	57T
Net Interest Expenses	-22T	-3T	63T	57T
EBT, Excl. Unusual Items	-12.13L	-7L	-35.05L	-34.07L
Impairment of Goodwill	-	-	-	-86.48L
Asset Writedown	-	-	-	-10.36L
EBT, Incl. Unusual Items	-12.13L	-7L	-35.05L	-1.31Cr
Income Tax Expense	-	-	-	4L
Earnings From Continuing Operations	-12.13L	-7L	-35.05L	-1.34Cr
Net Income to Company	-12.13L	-7L	-35.05L	-1.34Cr
Net Income - (IS)	-12.13L	-7L	-35.05L	-1.34Cr
Preferred Dividend and Other Adjustments	-	-	-14.21L	-
Net Income to Common Incl Extra Items	-12.13L	-7L	-20.84L	-1.34Cr
Net Income to Common Excl. Extra Items	-12.13L	-7L	-20.84L	-1.34Cr
Per Share Items
Net EPS - Basic	-0.04	-0.02	-0.03	-0.22
Basic EPS - Continuing Operations	-0.04	-0.02	-0.03	-0.22
Basic Weighted Average Shares Outstanding	2.81Cr	2.94Cr	6.07Cr	6.07Cr
Net EPS - Diluted	-0.04	-0.02	-0.03	-0.22
Diluted EPS - Continuing Operations	-0.04	-0.02	-0.03	-0.22
Diluted Weighted Average Shares Outstanding	2.81Cr	2.94Cr	6.07Cr	6.07Cr
Normalized Basic EPS	-0.03	-0.01	-0.04	-0.04
Normalized Diluted EPS	-0.03	-0.01	-0.04	-0.04
Supplemental Items
EBITDA	-11.89L	-7L	-35.64L	-34.58L
EBITA	-11.91L	-7L	-35.68L	-34.64L
EBIT	-11.91L	-7L	-35.68L	-34.64L
Effective Tax Rate - (Ratio)	-	-	-	-2.73
Normalized Net Income	-8L	-4L	-21.91L	-21.29L
Non-Cash Pension Expense	1T	1T	16T	49T
Supplemental Operating Expense Items
General and Administrative Expenses	11.24L	7L	14.1L	18.2L
Research And Development Expense From Footnotes	67T	7T	21.58L	16.44L
Stock-Based Comp., R&D Exp. (Total)	-	-	14.19L	1L
Stock-Based Comp., G&A Exp. (Total)	3L	45T	6L	5L
Total Stock-Based Compensation	3L	45T	19.99L	6L

Fiscal Period: December	2022	2023	2024	2025
Assets
Cash And Equivalents	4L	5L	32.68L	16.78L
Short Term Investments	-	49.5L	20.11L	10.33L
Total Cash And Short Term Investments	4L	54.8L	52.79L	27.11L
Other Receivables	11T	11T	44T	65T
Total Receivables	11T	11T	44T	65T
Prepaid Expenses	20T	37T	2L	3L
Other Current Assets, Total	-	1L	23T	35T
Total Current Assets	5L	56.28L	55.17L	30.95L
Net Property Plant And Equipment	3T	2T	9T	1L
Goodwill	-	-	1.14Cr	25.75L
Other Intangibles, Total	-	-	33.42L	24.97L
Total Assets	5L	56.3L	2.03Cr	82.96L
Liabilities
Accounts Payable, Total	50T	64T	1L	2L
Accrued Expenses, Total	-	-	2L	6L
Short-term Borrowings	1T	1T	1T	1T
Current Portion of Leases	-	-	-	55T
Deferred Tax Liability Current	-	-	2L	6L
Other Current Liabilities	19T	79T	2T	18T
Total Current Liabilities	70T	1L	6L	13.69L
Long-Term Leases	-	-	-	46T
Total Liabilities	70T	1L	6L	14.15L
Common Stock, Total	28T	34T	61T	61T
Additional Paid In Capital	50.02L	1.08Cr	3.04Cr	3.18Cr
Retained Earnings	-46.4L	-53.23L	-1.15Cr	-2.5Cr
Total Common Equity	4L	54.86L	1.89Cr	68.81L
Minority Interest	-	-	8L	-
Total Equity	4L	54.86L	1.97Cr	68.81L
Total Liabilities And Equity	5L	56.3L	2.03Cr	82.96L
Supplemental Items
ECS Total Shares Outstanding on Filing Date	2.81Cr	5.79Cr	6.07Cr	6.13Cr
ECS Total Common Shares Outstanding	2.81Cr	3.48Cr	6.07Cr	6.07Cr
Book Value / Share	0.01	0.16	0.31	0.11
Tangible Book Value	4L	54.86L	41.8L	18.09L
Tangible Book Value Per Share	0.01	0.16	0.07	0.03
Total Debt	1T	1T	1T	1L
Net Debt	-4L	-54.79L	-52.78L	-26.09L
Minority Interest, Total (Incl. Fin. Div)	-	-	8L	-
Account Code - Inventory Valuation	-	3	3	3
Full Time Employees	-	3	3	3
Part Time Employees	-	3	4	3

Fiscal Period: December	2022	2023	2024	2025
Net Income	-12.13L	-7L	-35.05L	-1.34Cr
Depreciation & Amortization - CF	2T	2T	4T	6T
Depreciation & Amortization, Total	2T	2T	4T	6T
Asset Writedown & Restructuring Costs	-	-	-	96.84L
Stock-Based Compensation (CF)	3L	45T	19.99L	6L
Other Operating Activities, Total	62T	-	-4T	4L
Change In Accounts Payable	-4T	14T	27T	21T
Change in Other Net Operating Assets	40T	-7T	3L	2L
Cash from Operations	-8L	-6L	-12.11L	-25.31L
Capital Expenditure	-2T	-1T	-3T	-7T
Cash Acquisitions	-	-	7L	-
Investment in Marketable and Equity Securities, Total	-	-49.5L	-20L	10L
Other Investing Activities, Total	-	-	-	-27T
Cash from Investing	-2T	-49.51L	-12.74L	9L
Issuance of Common Stock	4L	56.84L	3T	-
Cash from Financing	4L	56.84L	3T	-
Net Change in Cash	-4L	1L	-24.82L	-15.9L
Supplemental Items
Levered Free Cash Flow	-	-4L	3L	-10L
Unlevered Free Cash Flow	-	-4L	3L	-10L
Change In Net Working Capital	-	43T	-5L	-6L

Fiscal Period: December	2022	2023	2024	2025
Profitability
Return on Assets	-	-13.96	-20.42	-15.15
Return on Total Capital	-	-14.46	-21.14	-16.22
Return On Equity %	-	-23.25	-33.23	-101.17
Return on Common Equity	-	-23.25	-20.5	-104.19
Short Term Liquidity
Current Ratio	6.53	39.08	9.58	2.26
Quick Ratio	6.24	38.13	9.24	2.03
Operating Cash Flow to Current Liabilities	-11.73	-4.37	-2.1	-1.85
Long Term Solvency
Total Debt/Equity	0.26	0.02	0	1.48
Total Debt / Total Capital	0.26	0.02	0	1.46
LT Debt/Equity	-	-	-	0.67
Long-Term Debt / Total Capital	-	-	-	0.66
Total Liabilities / Total Assets	15.22	2.56	2.84	17.06
EBIT / Interest Expense	-54.14	-226.67	-1.78T	-
EBITDA / Interest Expense	-54.05	-226	-1.78T	-
(EBITDA - Capex) / Interest Expense	-54.14	-226.33	-1.78T	-
Total Debt / EBITDA	-0	-0	-0	-0.03
Net Debt / EBITDA	0.36	8.08	1.48	0.75
Total Debt / (EBITDA - Capex)	-0	-0	-0	-0.03
Net Debt / (EBITDA - Capex)	0.36	8.07	1.48	0.75
Growth Over Prior Year
EBITDA, 1 Yr. Growth %	-	-42.98	256.04	-2.97
EBITA, 1 Yr. Growth %	-	-42.91	256.09	-2.91
EBIT, 1 Yr. Growth %	-	-42.91	256.09	-2.91
Earnings From Cont. Operations, 1 Yr. Growth %	-	-43.69	255.12	283.71
Net Income, 1 Yr. Growth %	-	-43.69	255.12	283.71
Normalized Net Income, 1 Yr. Growth %	-	-43.69	255.12	-2.8
Diluted EPS Before Extra, 1 Yr. Growth %	-	-46.09	-	61.96
Net Property, Plant and Equip., 1 Yr. Growth %	-	-33.33	350	1.33T
Total Assets, 1 Yr. Growth %	-	1.12T	1.2T	-59.1
Tangible Book Value, 1 Yr. Growth %	-	1.31T	200.29	-56.72
Common Equity, 1 Yr. Growth %	-	1.31T	1.26T	-63.66
Cash From Operations, 1 Yr. Growth %	-	-23.39	19.43	109
Capital Expenditures, 1 Yr. Growth %	-	-50	0	133.33
Levered Free Cash Flow, 1 Yr. Growth %	-	-	-145.99	-413.79
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	-146.18	-412.5
Compound Annual Growth Rate Over Two Years
EBITDA, 2 Yr. CAGR %	-	-	73.13	85.86
EBITA, 2 Yr. CAGR %	-	-	73.08	85.93
EBIT, 2 Yr. CAGR %	-	-	73.08	85.93
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-	69.99	269.14
Net Income, 2 Yr. CAGR %	-	-	69.99	269.14
Normalized Net Income, 2 Yr. CAGR %	-	-	69.99	85.79
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	-10.82	-
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	73.21	703.12
Total Assets, 2 Yr. CAGR %	-	-	564.01	130.68
Tangible Book Value, 2 Yr. CAGR %	-	-	227.38	14
Common Equity, 2 Yr. CAGR %	-	-	596.81	122.33
Cash From Operations, 2 Yr. CAGR %	-	-	21.45	57.99
Capital Expenditures, 2 Yr. CAGR %	-	-	22.47	52.75
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-	20.13
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-	20.13
Compound Annual Growth Rate Over Three Years
EBITDA, 3 Yr. CAGR %	-	-	-	42.74
EBITA, 3 Yr. CAGR %	-	-	-	42.74
EBIT, 3 Yr. CAGR %	-	-	-	42.74
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-	122.99
Net Income, 3 Yr. CAGR %	-	-	-	122.99
Normalized Net Income, 3 Yr. CAGR %	-	-	-	41.09
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	72.49
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-	250.34
Total Assets, 3 Yr. CAGR %	-	-	-	162.24
Tangible Book Value, 3 Yr. CAGR %	-	-	-	66.77
Common Equity, 3 Yr. CAGR %	-	-	-	160.33
Cash From Operations, 3 Yr. CAGR %	-	-	-	45.54
Capital Expenditures, 3 Yr. CAGR %	-	-	-	51.83